UBS Group
KMTS

UBS Group’s Kestra Medical Technologies KMTS Stock Holding History

UBS Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.97M Buy
349,687
+79,629
+29% +$1.88M ﹤0.01% 3723
2025
Q4 		$7.16M Buy
270,058
+69,908
+35% +$1.8M ﹤0.01% 3661
2025
Q3 		$4.76M Buy
200,150
+127,026
+174% +$2.27M ﹤0.01% 4093
2025
Q2 		$1.21M Buy
73,124
+27,329
+60% +$597K ﹤0.01% 5276
2025
Q1 		$1.14M Buy
+45,795
New +$1.05M ﹤0.01% 5171

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

UBS Group's KMTS Position: Q1 2026 in Review

UBS Group increased its Kestra Medical Technologies (KMTS) stake by 29% in Q1 2026, buying an estimated $1.88M and bringing the position to 349,687 shares worth $6.97M. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

UBS Group first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $7.16M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • UBS Group held 349,687 shares of Kestra Medical Technologies worth $6.97M as of Q1 2026.
  • UBS Group bought 79,629 Kestra Medical Technologies shares in Q1 2026, an estimated $1.88M.
  • Kestra Medical Technologies made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3723 holding.
  • UBS Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • UBS Group's Kestra Medical Technologies position peaked at $7.16M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.